Company intelligence / Profile preview

ImPact Biotech

Ownership: Private
Development stage: Other

Overview

ImPact Biotech is an advanced clinical-stage oncology company developing Padeliporfin VTP, a minimally invasive photodynamic therapy platform. The lead program is in pivotal Phase 3 trials for low-grade upper tract urothelial carcinoma, with interim data showing efficacy comparable to standard of care but with reduced risk of organ injury or loss. Enrollment completion is expected by early 2025, supporting potential registration filings. Additional programs are planned or ongoing in high-grade UTUC, pancreatic ductal adenocarcinoma, and non-small cell lung cancer[4][5].

Therapeutic areas: Oncology
Modalities: Photodynamic therapy (Padeliporfin VTP)Drug-device combination (nonthermal laser activation of a photosensitizer)
Industry: Biotech

Drug pipeline

2 assets

padeliporfin VTP

1 more asset in the full pipeline.

Partnerships

Longstanding collaborations with the Weizmann Institute of Science and Memorial Sloan Kettering Cancer Center[4][5].

Beyond the preview

Go deeper on ImPact Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImPact Biotech.